Moreover, a specific mutation of the CDK4 gene (CDKR24C) that confers resistance to p16 INK4a binding has been shown to play a causal role in rare cases of familial melanoma, suggesting that unchecked CDK4 activity is a key event in these cancers [9]. Here, CDKN2A is linked to cancer.